BAYLINZ
Live / Allowed — First extension granted (statement of use) (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99323845
- Mark type
- Word mark
- Filed
- 06 Aug 2025
- Published for opposition
- 20 Jan 2026
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 09 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2026 — SOU EXTENSION 1 GRANTED
- 08 Sept 2026 — SOU EXTENSION 1 FILED
- 08 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Dec 2025 — ASSIGNED TO EXAMINER